Kenvue Inc. (NYSE:KVUE) Shares Acquired by Focus Financial Network Inc.

Focus Financial Network Inc. increased its holdings in Kenvue Inc. (NYSE:KVUE) by 9.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 12,624 shares of the company’s stock after buying an additional 1,095 shares during the period. Focus Financial Network Inc.’s holdings in Kenvue were worth $303,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of KVUE. Norges Bank acquired a new position in shares of Kenvue in the 4th quarter valued at about $521,348,000. Starboard Value LP acquired a new position in shares of Kenvue in the 4th quarter valued at about $467,864,000. Franklin Resources Inc. boosted its holdings in shares of Kenvue by 61.5% in the 4th quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company’s stock valued at $912,059,000 after buying an additional 16,269,721 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in shares of Kenvue by 12.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company’s stock valued at $2,085,070,000 after buying an additional 10,682,003 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Kenvue by 3.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company’s stock valued at $5,249,665,000 after buying an additional 8,211,748 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently weighed in on KVUE. Canaccord Genuity Group lifted their price objective on shares of Kenvue from $24.00 to $29.00 and gave the company a “buy” rating in a research report on Wednesday, March 5th. Barclays lifted their price objective on shares of Kenvue from $22.00 to $23.00 and gave the company an “equal weight” rating in a research report on Monday, May 12th. Citigroup lifted their price objective on shares of Kenvue from $22.00 to $24.50 and gave the company a “neutral” rating in a research report on Friday, May 9th. Redburn Atlantic began coverage on shares of Kenvue in a research report on Thursday, April 10th. They issued a “neutral” rating and a $23.50 price objective on the stock. Finally, UBS Group lifted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company a “neutral” rating in a research report on Friday, May 9th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and an average price target of $25.33.

Kenvue Stock Performance

Kenvue stock opened at $21.44 on Friday. The firm’s 50 day simple moving average is $23.02 and its 200-day simple moving average is $22.52. The company has a market cap of $41.14 billion, a P/E ratio of 40.46, a price-to-earnings-growth ratio of 2.62 and a beta of 0.98. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.01. The business had revenue of $3.74 billion for the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The firm’s quarterly revenue was down 3.9% compared to the same quarter last year. During the same period last year, the firm posted $0.28 earnings per share. As a group, equities research analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.82%. The ex-dividend date was Wednesday, May 14th. Kenvue’s payout ratio is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.